Amgen's blockbuster $10.4 billion bid to acquire Onyx Pharmaceuticals topped Modern Healthcare's list of largest mergers and acquisitions last month. However, total deals in August fell to 70, down from 99 in July. Acquisitions in the drugs and biologics sector continued to dominate merger activity with three of the five largest deals in that sector.
Deal pace slows in August
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.